Skip to Content

Imatinib Teva B.V.

Licence status
Withdrawn: 08/05/2018
Active substances
Imatinib, Imatinib mesilate
Dosage Form
Film-coated tablet
Licence number
EU/1/17/1243/001-012
Licence holder
Teva B.V.

Licence information

ATC code
L01XE Protein kinase inhibitors, L01XE01 imatinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/11/2017